|
|
Volumn 105, Issue 10, 2002, Pages 1182-1188
|
|
Tolerability of β-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)
a,g
|
|
Author keywords
Drugs; Heart failure; Receptors, adrenergic, beta
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
METOPROLOL;
PLACEBO;
ADULT;
AGED;
ARTICLE;
BETA ADRENERGIC RECEPTOR BLOCKING;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED RELEASE FORMULATION;
CONTROLLED STUDY;
DOSE CALCULATION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
HYPOTENSION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADRENERGIC BETA-ANTAGONISTS;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BLOOD PRESSURE;
DELAYED-ACTION PREPARATIONS;
DIURETICS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FATIGUE;
FEMALE;
HEART FAILURE, CONGESTIVE;
HEART RATE;
HUMANS;
MALE;
METOPROLOL;
MIDDLE AGED;
PATIENT COMPLIANCE;
PATIENT DROPOUTS;
RESPIRATION;
|
|
EID: 0037066022
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/hc1002.105180 Document Type: Article |
|
Times cited : (77)
|
|
References (9)
|
